Avigen Reports Second Quarter 2009 Financial Results
10. August 2009 12:59 ET
|
Avigen, Inc.
ALAMEDA, Calif., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its second quarter ended June 30, 2009. At June 30,...
Avigen Granted AV411 Patent for Neuropathic Pain
20. Mai 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., May 20, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, announced today that it has been granted United States Patent No. 7,534,806, entitled "Method...
Avigen Reports First Quarter 2009 Financial Results
11. Mai 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., May 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its first quarter ended March 31, 2009. At March 31,...
Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight
31. März 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that based on the final tabulation of votes reported by the independent...
Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation
26. März 2009 09:21 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 26, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors has discontinued its strategic merger...
Leading Independent Advisory Service Urges Avigen Stockholders to Reject BVF's Proposal
18. März 2009 14:40 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors issued the following comments in a letter to...
Avigen's Board Urges Stockholders to Reject BVF's Proposal
11. März 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that it has scheduled a Special Meeting of Stockholders as requested by...
Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction
25. Februar 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that two preclinical reports with glial attenuator AV411 (ibudilast) support...
Avigen Reports 2008 Financial Results and Updates Progress On Strategic Review
11. Februar 2009 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2008. At...
Avigen Board Rejects BVF Offer as Inadequate
06. Februar 2009 08:00 ET
|
Avigen, Inc.
Recommends Stockholders Not Tender Shares
Company Reviewing Strategic Alternatives
ALAMEDA, Calif., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a...